15 results
8-K
EX-99.1
MYMD
MyMD Pharmaceuticals Inc
19 Oct 23
MyMD Announces Preclinical Study Results Showing Novel Cannabidiol Analog, Supera-CBD™, Reduced
9:00am
related to touch in the model of inflammation. This may indicate the potential for fewer side effects compared to traditional opioid pain treatments
424B5
MYMD
MyMD Pharmaceuticals Inc
17 Aug 22
Prospectus supplement for primary offering
3:00pm
to treat various conditions, including, but not limited to, epilepsy, pain and anxiety/depression, through its effects on the CB2 receptor, opioid
8-K
EX-99.1
miucotrzc4 6na
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
425
oavh66mmyp37 tm8c
13 Apr 21
Business combination disclosure
9:05am
425
s1sln7z
12 Apr 21
Business combination disclosure
9:21am
425
4n7u1c eg2
22 Mar 21
Business combination disclosure
5:21pm
425
fy9zky1evsl klf458
18 Feb 21
Business combination disclosure
9:00am
425
0hou3o6ri0wxt3rw8p9r
2 Dec 20
Business combination disclosure
4:59pm
425
k0oaadq7pagm6ax9kpzl
19 Nov 20
Business combination disclosure
8:48am
8-K
EX-99.1
6seotcun945
18 Nov 20
Other Events
4:52pm
425
EX-99.1
ox8eno0q7xrvb dxz
18 Nov 20
Business combination disclosure
4:50pm
8-K
EX-99.1
3dve3q
12 Nov 20
Akers Biosciences and MyMD Pharmaceuticals Sign Definitive Merger Agreement
5:26pm
- Prev
- 1
- Next